Eduardo Oliveira

Prof. Eduardo Oliveira

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in The Lancet Child & Adolescent Health
Verified
Journal Article
Closed access
EOEduardo Oliveira
Eduardo Oliveira
ECEnrico A Colosimo
Enrico A Colosimo
ASAna Cristina Simões e Silva
Ana Cristina Simões e Silva
RMRobert H Mak
Robert H Mak
DMDaniella B Martelli
Daniella B Martelli
MOMaria Christina L Oliveira
Maria Christina L Oliveira

26 November 2019 in Jornal de Pediatria
Verified
Journal Article
Open access
ASAna Cristina Simões e Silva
Ana Cristina Simões e Silva
EOEduardo Oliveira
Eduardo Oliveira
RMRobert H. K. Mak
Robert H. K. Mak
This review aimed to provide a critical overview on the pathogenesis, clinical findings, diagnosis, imaging investigation, treatment, chemoprophylaxis, and complications of urinary tract infection in pediatric patients. Data were obtained independently by two authors, who carried out a comprehensive and non-systematic search in public databases. Urinary tract infection is the most common bacterial infection in children. Urinary tract infection in pediatric patients can be the early clinical manifestation of congenital anomalies of the kidney and urinary tract (CAKUT) or be related to bladder dysfunctions. E. coli is responsible for 80-90% of community-acquired acute pyelonephritis episodes, especially in children. Bacterial virulence factors and the innate host immune systems may contribute to the occurrence and severity of urinary tract infection. The clinical presentation of urinary tract infections in children is highly heterogeneous, with symptoms that can be quite obscure. Urine culture is still the gold standard for diagnosing urinary tract infection and methods of urine collection in individual centers should be determined based on the accuracy of voided specimens. The debate on the ideal imaging protocol is still ongoing and there is tendency of less use of prophylaxis. Alternative measures and management of risk factors for recurrent urinary tract infection should be emphasized. However, in selected patients, prophylaxis can protect from recurrent urinary tract infection and long-term consequences. According to population-based studies, hypertension and chronic kidney disease are rarely associated with urinary tract infection. Many aspects regarding urinary tract infection in children are still matters of debate, especially imaging investigation and indication of antibiotic prophylaxis. Further longitudinal studies are needed to establish tailored approach of urinary tract infection in childhood.

9 March 2012 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
BMBatielhe F. Melo
Batielhe F. Melo
MAMarcos B. Aguiar
Marcos B. Aguiar
MBMaria Candida F. Bouzada
Maria Candida F. Bouzada
RARegina L. Aguiar
Regina L. Aguiar
APAlamanda K. Pereira
Alamanda K. Pereira
EOEduardo Oliveira
Eduardo Oliveira

1 March 2012 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
IQIsabel G. Quirino
Isabel G. Quirino
JDJose Silverio S. Diniz
Jose Silverio S. Diniz
MBMaria Candida F. Bouzada
Maria Candida F. Bouzada
APAlamanda K. Pereira
Alamanda K. Pereira
TLThais J. Lopes
Thais J. Lopes
EOEduardo Oliveira
Eduardo Oliveira
Summary: Background and objectives: With the advent of fetal screening ultrasonography, the detection of congenital anomalies of the kidney and urinary tract (CAKUT) in utero has permitted early management of these conditions. This study aims to describe the clinical course of a large cohort of patients with prenatally detected nephrouropathies. Design, setting, participants, & measurements: In this retrospective cohort study, 822 patients were prenatally diagnosed with CAKUT and systematically followed up at a tertiary Renal Unit for a median time of 43 months. Variables included in the analysis were sex, laterality, fetal ultrasonography (isolated versus associated hydronephrosis), and presence/absence of nephrouropathies. The events of interest were urinary tract infection, surgical interventions, hypertension, CKD, and death. Survival analyses were performed to evaluate time until occurrence of the events of interest. Results: Urinary tract infection occurred in 245 (29.8%) children, with higher risk in females (hazard ratio=1.30, 95% confidence interval=1.02–1.70, P =0.05); 22 patients (2.7%) had hypertension, and 49 (6%) patients developed CKD. The risk of CKD was greater in patients with associated hydronephrosis (hazard ratio=5.20, 95% confidence interval=2.90–9.30, P <0.001). Twelve patients (1.5%) died during follow-up. Death was significantly associated with being born during the first period of the study (hazard ratio=6.00, 95% confidence interval=1.60–22.50, P <0.001), associated hydronephrosis (hazard ratio=9.30, 95% confidence interval=2.90–29.30, P <0.001), and CKD (hazard ratio=170.00, 95% confidence interval=41.00–228.00, P <0.001). Conclusions: In our series, the clinical course of prenatally detected CAKUT was heterogeneous, and those infants with associated hydronephrosis at baseline were identified as a high-risk subgroup.

1 March 2021 in Jornal de Pediatria
Verified
Journal Article
Open access
PPPedro pousa
Pedro pousa
TMTamires S.C. Mendonça
Tamires S.C. Mendonça
EOEduardo Oliveira
Eduardo Oliveira
ASAna Cristina Simões e Silva
Ana Cristina Simões e Silva
The aim of this review was to summarize the most common extrapulmonary manifestations in pediatric patients with COVID-19, as well as to discuss clinical, epidemiological, and pathophysiological aspects of these clinical presentations in children. An extensive search of literature was performed in order to identify pediatric cases with extrapulmonary manifestations between January 1, 2020 and June 21, 2020. Generic keywords, such as “Novel coronavirus” or “Novel coronavirus 2019” or “2019 nCoV” or “COVID-19” or “SARS-CoV-2” were searched on PubMed database, associated either with age filters or generic pediatric terms. A total of 28 articles, including 199 patients, were considered suitable to review and data extraction. The main findings were summarized in tables. The main non-pulmonary manifestations in pediatric patients, in decreasing order of frequency, were gastrointestinal, renal, cardiovascular, neurological, hematological and lymphatic, cutaneous, hepatic, ocular, olfactory, and gustatory. Multisystem impairment and Kawasaki-like disease were also described. Differences in immune response of children and variations of tissue expression of angiotensin converting enzyme 2, the virus receptor, are likely to influence clinical, epidemiological, and pathophysiological patterns of the disease.

1 April 2021 in Seminars in Oncology
Verified
Journal Article
Closed access
NMNelson Pereira Marques
Nelson Pereira Marques
DSDenise Maria M. Silveira
Denise Maria M. Silveira
NMNádia Carolina Teixeira Marques
Nádia Carolina Teixeira Marques
DMDaniella Reis Barbosa Martelli
Daniella Reis Barbosa Martelli
EOEduardo Oliveira
Eduardo Oliveira
HMHercílio Martelli-Júnior
Hercílio Martelli-Júnior